You are here

Echinacea for Upper Respiratory Infection (URI) in Pediatrics , (UW subcontractor)

Status

Completed

Study area

Botanical Medicine
Immunity

Principal investigator

J Taylor

Co-investigators

Leanna J Standish
Carlos Calabrese

Project period

April 1, 2000 - March 31, 2002

Funded by

NIH/NCCAM

A collaboration with the University of Washington.

Purpose of Research
The proposed study is a randomized, double blind, placebo-controlled trial of echinacea for the treatment of upper respiratory infections (URIs) in children between the ages of two and 11. The aims of the project are to determine the following:

  1. Does echinacea shorten the duration and/or lessen the severity of URIs?
  2. Do children receiving echinacea for treatment of URIs have a reduced rate of secondary bacterial infections?
  3. Is the use of echinacea in patients between the ages of two and 11 associated with any significant side effects?

Research Objectives
A two-year-study of 600 children is planned. Not only will the results of this study determine if echinacea, the most popular medicinal herb sold in the United States, is an effective therapy for URIs in children, but the study will also provide a design framework for future assessments on the efficacy of complementary and alternative medicines in children.